391 related articles for article (PubMed ID: 26632601)
41. Astaxanthin prevents TGFβ1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells.
Yang Y; Kim B; Park YK; Koo SI; Lee JY
Biochim Biophys Acta; 2015 Jan; 1850(1):178-85. PubMed ID: 25450180
[TBL] [Abstract][Full Text] [Related]
42. Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cells.
Patel P; West-Mays J; Kolb M; Rodrigues JC; Hoff CM; Margetts PJ
Matrix Biol; 2010 Mar; 29(2):97-106. PubMed ID: 19896531
[TBL] [Abstract][Full Text] [Related]
43. The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways.
Zhang K; Han X; Zhang Z; Zheng L; Hu Z; Yao Q; Cui H; Shu G; Si M; Li C; Shi Z; Chen T; Han Y; Chang Y; Yao Z; Han T; Hong W
Nat Commun; 2017 Jul; 8(1):144. PubMed ID: 28747678
[TBL] [Abstract][Full Text] [Related]
44. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
[TBL] [Abstract][Full Text] [Related]
45. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats.
He J; Bai K; Hong B; Zhang F; Zheng S
Int Immunopharmacol; 2017 Dec; 53():56-62. PubMed ID: 29035816
[TBL] [Abstract][Full Text] [Related]
46. Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling.
Nakamura I; Zakharia K; Banini BA; Mikhail DS; Kim TH; Yang JD; Moser CD; Shaleh HM; Thornburgh SR; Walters I; Roberts LR
PLoS One; 2014; 9(4):e92273. PubMed ID: 24710173
[TBL] [Abstract][Full Text] [Related]
47. Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury.
Yoshida K; Matsuzaki K; Mori S; Tahashi Y; Yamagata H; Furukawa F; Seki T; Nishizawa M; Fujisawa J; Okazaki K
Am J Pathol; 2005 Apr; 166(4):1029-39. PubMed ID: 15793284
[TBL] [Abstract][Full Text] [Related]
48. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways.
Li J; Li X; Xu W; Wang S; Hu Z; Zhang Q; Deng X; Wang J; Zhang J; Guo C
Liver Int; 2015 Apr; 35(4):1222-33. PubMed ID: 25040634
[TBL] [Abstract][Full Text] [Related]
49. Platelet-derived growth factor-D modulates extracellular matrix homeostasis and remodeling through TIMP-1 induction and attenuation of MMP-2 and MMP-9 gelatinase activities.
Borkham-Kamphorst E; Alexi P; Tihaa L; Haas U; Weiskirchen R
Biochem Biophys Res Commun; 2015 Feb; 457(3):307-13. PubMed ID: 25576870
[TBL] [Abstract][Full Text] [Related]
50. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis.
Nevzorova YA; Hu W; Cubero FJ; Haas U; Freimuth J; Tacke F; Trautwein C; Liedtke C
Biochim Biophys Acta; 2013 Oct; 1832(10):1765-75. PubMed ID: 23770341
[TBL] [Abstract][Full Text] [Related]
52. Effect of fetuin, a TGFbeta antagonist and pentoxifylline, a cytokine antagonist on hepatic stellate cell function and fibrotic parameters in fibrosis.
Verma-Gandhu M; Peterson MR; Peterson TC
Eur J Pharmacol; 2007 Oct; 572(2-3):220-7. PubMed ID: 17678645
[TBL] [Abstract][Full Text] [Related]
53. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats.
Zhong W; Shen WF; Ning BF; Hu PF; Lin Y; Yue HY; Yin C; Hou JL; Chen YX; Zhang JP; Zhang X; Xie WF
Hepatology; 2009 Nov; 50(5):1524-36. PubMed ID: 19787807
[TBL] [Abstract][Full Text] [Related]
55. New role and molecular mechanism of Gadd45a in hepatic fibrosis.
Hong L; Sun QF; Xu TY; Wu YH; Zhang H; Fu RQ; Cai FJ; Zhou QQ; Zhou K; Du QW; Zhang D; Xu S; Ding JG
World J Gastroenterol; 2016 Mar; 22(9):2779-88. PubMed ID: 26973416
[TBL] [Abstract][Full Text] [Related]
56. The common dietary flavonoid myricetin attenuates liver fibrosis in carbon tetrachloride treated mice.
Geng Y; Sun Q; Li W; Lu ZM; Xu HY; Shi JS; Xu ZH
Mol Nutr Food Res; 2017 Apr; 61(4):. PubMed ID: 27983763
[TBL] [Abstract][Full Text] [Related]
57. β-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis.
Kocabayoglu P; Lade A; Lee YA; Dragomir AC; Sun X; Fiel MI; Thung S; Aloman C; Soriano P; Hoshida Y; Friedman SL
J Hepatol; 2015 Jul; 63(1):141-7. PubMed ID: 25678385
[TBL] [Abstract][Full Text] [Related]
58. Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cells.
Klironomos S; Notas G; Sfakianaki O; Kiagiadaki F; Xidakis C; Kouroumalis E
Regul Pept; 2014 Jan; 188():5-12. PubMed ID: 24291170
[TBL] [Abstract][Full Text] [Related]
59. Loss of steroid receptor co-activator-3 attenuates carbon tetrachloride-induced murine hepatic injury and fibrosis.
Ma X; Xu L; Wang S; Chen H; Xu J; Li X; Ning G
Lab Invest; 2009 Aug; 89(8):903-14. PubMed ID: 19488034
[TBL] [Abstract][Full Text] [Related]
60. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.
Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM
Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
